Skip to main content
logo
Hikma Pharmaceuticals PLC (LON:HIK)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1,350.00
+7.00 (0.52%)
Apr 17, 2026, 8:24 AM GMT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Others
40.00M26.00M21.00M14.00M11.00M
Others Growth
53.85%23.81%50.00%27.27%57.14%
Hikma Rx
1.04B1.03B937.00M672.00M820.00M
Hikma Rx Growth
1.07%9.50%39.43%-18.05%10.22%
Injectables
1.42B1.31B1.20B1.14B1.05B
Injectables Growth
8.96%8.56%5.53%8.26%7.78%
Branded
849.00M769.00M714.00M691.00M669.00M
Branded Growth
10.40%7.70%3.33%3.29%9.14%
Total
3.35B3.13B2.88B2.52B2.55B
Total Growth
7.10%8.77%14.22%-1.41%9.06%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
North America (Excl. United States)
26.00M24.00M23.00M18.00M-
North America (Excl. United States) Growth
8.33%4.35%27.78%--
Europe and Rest of the World
270.00M218.00M206.00M192.00M189.00M
Europe and Rest of the World Growth
23.85%5.83%7.29%1.59%18.87%
Other Middle East and North Africa
529.00M471.00M459.00M379.00M390.00M
Other Middle East and North Africa Growth
12.31%2.61%21.11%-2.82%-9.09%
United Kingdom
14.00M13.00M11.00M8.00M6.00M
United Kingdom Growth
7.69%18.18%37.50%33.33%0%
United States
1.95B1.89B1.73B1.43B1.51B
United States Growth
3.34%9.33%20.45%-5.16%7.47%
Saudi Arabia
331.00M301.00M261.00M240.00M218.00M
Saudi Arabia Growth
9.97%15.33%8.75%10.09%-2.24%
Algeria
229.00M213.00M189.00M132.00M112.00M
Algeria Growth
7.51%12.70%43.18%17.86%-
Egypt
---115.00M127.00M
Egypt Growth
----9.45%7.63%
Total
3.35B3.13B2.88B2.52B2.55B
Total Growth
7.10%8.77%14.22%-1.41%9.06%
Source: S&P Global Market Intelligence.